Recent Finacing
Recent Raise
MeMed develops host-response diagnostics and point-of-care instruments (ImmunoXpert/MeMed Key) that measure a three-protein signature (TRAIL, IP-10, CRP) to differentiate bacterial from viral infections.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at MeMed.
